Skip to main content
    A

    Anixa Biosciences Inc (ANIX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.55
    -0.07 (-2.67%)

    Market Cap: $88.65M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Anixa Biosciences Inc (ANIX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Anixa Biosciences (ANIX) has a market cap of $88.65M and an enterprise value of $87.25M. Its share count is up 5.25% from a year earlier.

    Total Valuation

    Enterprise value is 1.58% below the market cap, as cash exceeds debt.

    Market Cap$88.65M
    Enterprise Value$87.25M
    Latest price (Nov 17, 2026)$2.55

    Key Dates

    The next earnings report is set for Jan 11, 2027, after the close.

    Next Earnings DateJan 11, 2027, after the close
    Last Earnings DateSep 9, 2026
    Fiscal Year EndOctober

    Share Statistics

    The share count rose 1.75% in the quarter ended Jul 31, 2026 and grew 3.27% a year over 2 years.

    Shares Outstanding34.18M
    Shares Change (YoY)+5.25%
    Shares Change (QoQ)+1.75%
    Share Count Growth (2Y CAGR)+3.27%

    Price Statistics

    The stock is down 41.91% over 52 weeks and trades 11.15% below its 50-day average.

    Beta (1Y)1.50
    52-Week Change-41.91%
    1-Month Change-4.49%
    3-Month Change-25.66%
    6-Month Change-7.61%
    5-Year Change-34.59%
    10-Year Change-50.87%
    Total Return (1Y)-41.91%
    Total Return (3Y CAGR)-4.74%
    Total Return (5Y CAGR)-8.39%
    Return vs SPY (1Y)-49.36%
    Max Drawdown (1Y)-54.98%
    Max Drawdown (3Y)-57.57%
    Sharpe Ratio (1Y)-0.71
    Correlation with SPY (1Y)0.31
    50-Day Average$2.87
    200-Day Average$2.96
    52-Week Range$2.32 to $5.46
    RSI (14 Days)37.6
    Average Volume (20 Days)199.49K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 8.54x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio8.54x
    Quick Ratio8.54x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -72.34% over the last 12 months, against a 5-year average of -52.20%.

    Return on Equity (ROE)-72.34%
    Return on Assets (ROA)-69.44%
    ROE (5Y Average)-52.20%
    ROA (5Y Average)-49.46%
    ROIC (5Y Average)-55.30%

    Scores

    ANIX has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Gross Profit-$9.00K
    Operating Income-$10.98M
    Pretax Income-$10.47M
    Net Income-$10.47M
    Reported EPS (TTM)-$0.31

    Trailing 12 months through Jul 31, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 96.02% of the $15.07M in total assets.

    Cash and Equivalents$1.40M
    Total Debt$0
    Net Cash$1.40M
    Net Cash Per Share$0.04
    Working Capital$13.17M
    Shareholder Equity$14.47M
    Book Value Per Share$0.42
    Total Assets$15.07M
    Total Liabilities$1.87M

    Balance sheet as of Jul 31, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$7.38M
    FCF Per Share-$0.21
    Depreciation and Amortization$134.00K

    Trailing 12 months through Jul 31, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-22.76%
    Tangible Book Per Share Growth (2Y CAGR)-22.76%

    Revenue and profit by year

    Dividends and Yields

    ANIX does not pay a dividend.

    Buyback Yield-2.75%
    Shareholder Yield-2.75%

    Stock Splits

    The last split was a 1-for-25 reverse split on Jun 26, 2015.

    Last Split DateJun 26, 2015
    Split TypeReverse split
    Split Ratio1:25

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About ANIX

    What is ANIX's market cap?

    Anixa Biosciences has a market cap of $88.65M. Its enterprise value, which adds debt and subtracts cash, is $87.25M.

    How many shares of ANIX are outstanding?

    Anixa Biosciences has 34.18M shares outstanding. The count is up 5.25% from a year earlier.

    Does ANIX pay a dividend?

    No. Anixa Biosciences does not pay a dividend.

    How much debt does ANIX have?

    Anixa Biosciences has $0 of total debt and $1.40M of cash and equivalents, a net cash position of $1.40M.